Skip to main content

Table 2 Subgroup analyses showing difference between studies included in the meta-analysis (highest versus lowest BMI)

From: Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies

Variables

Number of studies

Number of cases

Pooled RR (95%CI)

Test of heterogeneity

Publication bias

I2(%)

P value

Begg's P value

Egger's P value

All

20

30938

1.10 (1.06, 1.15)

43.0

0.022

0.538

0.003

Area

 Asia

3

2968

1.18 (1.08, 1.30)

0.0

0.555

1.000

0.339

 Europe

8

19791

1.08 (1.05, 1.12)

44.6

0.082

0.266

0.116

 America

8

3847

1.13 (1.04, 1.23)

47.4

0.065

0.902

0.079

Menopausal

 Pre

5

4291

1.12 (1.04, 1.20)

31.6

0.211

0.806

0.489

 Post

6

4479

1.28 (1.14, 1.44)

0.0

0.865

0.452

0.656

Study period

 ≤ 5y

6

2250

1.31 (1.14, 1.50)

0.0

0.709

0.707

0.860

 > 5y

14

28688

1.07 (1.05, 1.10)

26.8

0.167

0.743

0.051

Study population

 TNBC

2

429

1.15 (0.88, 1.49)

0.0

0.789

1.000

---

 Non-TNBC

18

30539

1.08 (1.06, 1.11)

48.2

0.012

0.363

0.003

  1. TNBC Triple-negative breast cancer